Organisation paid for research Program year 2024 Source: CMS Open Payments

Axon Capital, LLC

Neither a doctor nor a teaching hospital

Research payments

$46,132

23 payments

Through program year 2024, Axon Capital, LLC is reported as receiving $46,132 in research payments, across 23 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$8,375	4
2023	Research	$37,757	19

Breakdown

Who paid Research payments · program years 2023–2024

Arcutis Biotherapeutics, Inc. $46,132 23 payments

Studies the money was for Research payments · program years 2023–2024

A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis $23,095 14 payments
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.05% Administered QD in Subjects with Atopic Dermatitis $12,373 5 payments
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects with Atopic Dermatitis $10,664 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.